Cargando…
Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics
OBJECTIVE: Schizophrenia (SCZ) is a severe psychiatric disorder with unknown etiology and lacking specific biomarkers. Herein, we aimed to explore plasma biomarkers relevant to SCZ using targeted metabolomics. METHODS: Sixty drug-naïve SCZ patients and 36 healthy controls were recruited. Psychotic s...
Autores principales: | Su, Qiao, Bi, Fuyou, Yang, Shu, Yan, Huiming, Sun, Xiaoxiao, Wang, Jiayue, Qiu, Yuying, Li, Meijuan, Li, Shen, Li, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555515/ https://www.ncbi.nlm.nih.gov/pubmed/37794663 http://dx.doi.org/10.30773/pi.2023.0121 |
Ejemplares similares
-
Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
por: Qiu, Yuying, et al.
Publicado: (2023) -
Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study
por: Jiang, Yihe, et al.
Publicado: (2022) -
Schizophrenia shows a unique metabolomics signature in plasma
por: He, Y, et al.
Publicado: (2012) -
Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents
por: Jiang, Yuanliang, et al.
Publicado: (2022) -
Metabolomics in the Identification of Biomarkers of Asthma
por: Villaseñor, Alma, et al.
Publicado: (2021)